Nisa Investment Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.9K | Buy |
996
+609
| +157% | +$17.1K | ﹤0.01% | 2087 |
|
|
2026
Q1 | $11K | Hold |
387
| – | – | ﹤0.01% | 2210 |
|
|
2025
Q4 | $15.3K | Sell |
387
-220
| -36% | -$8.06K | ﹤0.01% | 2051 |
|
|
2025
Q3 | $21.4K | Sell |
607
-8
| -1% | -$276 | ﹤0.01% | 1965 |
|
|
2025
Q2 | $20.2K | Buy |
615
+8
| +1% | +$260 | ﹤0.01% | 1934 |
|
|
2025
Q1 | $19.6K | Hold |
607
| – | – | ﹤0.01% | 1887 |
|
|
2024
Q4 | $18.6K | Sell |
607
-9
| -1% | -$289 | ﹤0.01% | 1960 |
|
|
2024
Q3 | $17.3K | Buy |
616
+101
| +20% | +$2.49K | ﹤0.01% | 1952 |
|
|
2024
Q2 | $11.7K | Sell |
515
-6
| -1% | -$138 | ﹤0.01% | 2098 |
|
|
2024
Q1 | $15.8K | Buy |
521
+39
| +8% | +$1.31K | ﹤0.01% | 1953 |
|
|
2023
Q4 | $17.2K | Sell |
482
-520
| -52% | -$19.3K | ﹤0.01% | 1921 |
|
|
2023
Q3 | $43.9K | Hold |
1,002
| – | – | ﹤0.01% | 1763 |
|
|
2023
Q2 | $49.5K | Buy |
1,002
+280
| +39% | +$12.9K | ﹤0.01% | 1752 |
|
|
2023
Q1 | $30K | Hold |
722
| – | – | ﹤0.01% | 1875 |
|
|
2022
Q4 | $32K | Hold |
722
| – | – | ﹤0.01% | 1909 |
|
|
2022
Q3 | $30K | Buy |
722
+32
| +5% | +$1.46K | ﹤0.01% | 1927 |
|
|
2022
Q2 | $28K | Sell |
690
-940
| -58% | -$44.5K | ﹤0.01% | 1935 |
|
|
2022
Q1 | $107K | Sell |
1,630
-130
| -7% | -$8.42K | ﹤0.01% | 1593 |
|
|
2021
Q4 | $116K | Sell |
1,760
-260
| -13% | -$18.9K | ﹤0.01% | 1462 |
|
|
2021
Q3 | $140K | Hold |
2,020
| – | – | ﹤0.01% | 1550 |
|
|
2021
Q2 | $160K | Buy |
2,020
+420
| +26% | +$30.5K | ﹤0.01% | 1482 |
|
|
2021
Q1 | $105K | Hold |
1,600
| – | – | ﹤0.01% | 1726 |
|
|
2020
Q4 | $89K | Buy |
1,600
+400
| +33% | +$17.3K | ﹤0.01% | 1783 |
|
|
2020
Q3 | $48K | Buy |
+1,200
| New | +$50.9K | ﹤0.01% | 1823 |
|
|
2018
Q3 | – | Sell |
-530
| Closed | -$14K | – | 1967 |
|
|
2018
Q2 | $14K | Hold |
530
| – | – | ﹤0.01% | 1614 |
|
|
2018
Q1 | $11K | Hold |
530
| – | – | ﹤0.01% | 1619 |
|
|
2017
Q4 | $10K | Hold |
530
| – | – | ﹤0.01% | 1734 |
|
|
2017
Q3 | $12K | Hold |
530
| – | – | ﹤0.01% | 1685 |
|
|
2017
Q2 | $13K | Hold |
530
| – | – | ﹤0.01% | 1619 |
|
|
2017
Q1 | $10K | Sell |
530
-470
| -47% | -$8.23K | ﹤0.01% | 1661 |
|
|
2016
Q4 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 1637 |
|
|
2016
Q3 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 1713 |
|
|
2016
Q2 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 1723 |
|
|
2016
Q1 | $17K | Buy |
+1,000
| New | +$17.6K | ﹤0.01% | 1656 |
|
Other funds holding ATRC
HRCM
NAMI
Nisa Investment Advisors's ATRC Position: Q2 2026 in Review
Nisa Investment Advisors increased its AtriCure (ATRC) stake by 157% in Q2 2026, buying an estimated $17.1K and bringing the position to 996 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2087.
Nisa Investment Advisors first reported a position in ATRC in Q1 2016 and has held it in 34 quarters since. The position peaked at $160K in Q2 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Nisa Investment Advisors held 996 shares of AtriCure worth $27.9K as of Q2 2026.
- Nisa Investment Advisors bought 609 AtriCure shares in Q2 2026, an estimated $17.1K.
- AtriCure made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2087 holding.
- Nisa Investment Advisors first reported a position in AtriCure in Q1 2016 and has held it in 34 quarters since.
- Nisa Investment Advisors's AtriCure position peaked at $160K in Q2 2021.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.